PAD Toolkit for Health Care Professionals

Save the legs. Save the feet. Save the heart.

Featured Tools

PAD Toolkit Go To Guide cover

PAD Go-To-Guide for Health Care Professionals

Our guide is an easy-to-use, interactive tool that empowers doctors and nurses to engage patients diagnosed with peripheral artery disease. Access resources and the AHA’s latest patient engagement tools to deliver effective patient education.

Access now 

PAD Webinars (non-CME)

Managing PAD

View the three-part PAD Webinar Series created by the American Heart Association through an educational fund from Janssen. Pad experts discuss assessing, treating and managing peripheral artery disease in diverse communities. Topics include: the clinical assessment of PAD on the primary care spectrum with Dr. Eileen Walsh; treating PAD in underserved communities with Dr. Antonio Gutierrez and Dr. Amy West Pollack; and exercise therapy for PAD patients with Dr. Diane Treat-Jacobson.

Visit the three-part PAD Webinar Series

Recognizing the Signs and Symptoms of PAD

Amy Pollak, M.D., Mayo Clinic (cardiovascular medicine) speaks about detecting and diagnosing PAD, a disease that affects more than 113 million adults worldwide and over 8.5 million adults over age 40 in the United States. While it’s a serious risk factor for coronary artery disease and cerebrovascular disease, PAD remains a largely overlooked condition.

Watch the webinar.

Peripheral Artery Disease Roundtable Report

In December 2018, the American Heart Association and National Heart, Lung, and Blood Institute jointly convened multidisciplinary health care professionals representing over 40 health organizations to a PAD Roundtable. They identified strategies to improve public awareness of PAD prevention and increase awareness of PAD recognition and management among patients and health care professionals. The outcome of the session is the PAD Roundtable Report.

Access the report (PDF)

etc talk™

Part of a series of etc talks created by the Anticoagulation Forum, Dr. Jeffrey Weitz gets to the heart of issues surrounding vascular health in under 10 minutes, with highlights from a recent study on combination therapy in vascular protection. Discover how treatment can benefit patients by reducing cardiovascular events while balancing risk of increased bleeding by exploring the COMPASS trial with Dr. Weitz.

View this series of etc talks(link opens in new window)

Whiteboard Video

In less than three minutes, Dr. Jeffrey Weitz will provide a simple graphic overview of how blood clots form and how to minimize risk factors associated with blood clots that can lead to heart attack, stroke and peripheral artery disease.

View the Whiteboard Video(link opens in new window)

Ticagrelor Webinar

Data suggests that patients with symptomatic peripheral artery disease taking clopidogrel have a lower risk of cardiovascular events than those receiving aspirin. How does clopidogrel compare with ticagrelor in reducing major bleeding among these patients? Dr. Will Hiatt, lead author from the University of Colorado, explains this in depth during the 45-minute webinar.

View the Ticagrelor Webinar(link opens in new window)

Resources for your Patients

PAD Fact Sheet

Help your patients understand the risk factors, signs and symptoms and treatments for PAD. 

PAD vs PVD fact sheet

Download now (PDF)

Talking to Your Patients About PAD

Remind your team that educating your patients about PAD and its treatments should begin with explaining the disease and its risks.

Download now (PDF)

Additional Patient Resources:

Video: Top 3 Reasons to Take Your Socks Off

PAD Symptoms and Risk Factors

If you have cramping, tingling or weakness in your legs, you might have peripheral artery disease, also known as PAD. PAD can lead to leg or foot amputation and even heart attack or stroke. Early detection is key!

If you have trouble with your feet or legs, talk to a doctor about PAD and ask to take off your socks.

PAD Educational Series

Hear from medical experts and patients living with PAD in our podcast and video series.